Article Details

Chugai Pharmaceutical : Actemra Approved for Additional Indication of SARS-CoV-2 ...

Retrieved on: 2022-01-21 13:17:14

Tags for this article:

Click the tags to see associated articles and topics

Chugai Pharmaceutical : Actemra Approved for Additional Indication of SARS-CoV-2 .... View article details on hiswai:

Excerpt

Roche's Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children (Press ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up